Leone, Antonio Maria
 Distribuzione geografica
Continente #
EU - Europa 9.083
NA - Nord America 8.690
AS - Asia 6.748
SA - Sud America 1.467
AF - Africa 182
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 22
Totale 26.217
Nazione #
US - Stati Uniti d'America 8.464
DE - Germania 4.085
SG - Singapore 3.375
CN - Cina 1.830
SE - Svezia 1.226
BR - Brasile 1.194
IT - Italia 824
FR - Francia 590
UA - Ucraina 526
GB - Regno Unito 467
IE - Irlanda 349
VN - Vietnam 320
ID - Indonesia 252
FI - Finlandia 230
IN - India 225
PL - Polonia 203
RU - Federazione Russa 177
TR - Turchia 127
AR - Argentina 125
CA - Canada 97
HK - Hong Kong 87
BD - Bangladesh 81
MX - Messico 77
JP - Giappone 74
NL - Olanda 73
AT - Austria 70
IQ - Iraq 69
BE - Belgio 56
KR - Corea 52
ES - Italia 48
ZA - Sudafrica 41
CO - Colombia 36
IR - Iran 35
VE - Venezuela 30
MA - Marocco 29
EC - Ecuador 27
JO - Giordania 27
LT - Lituania 26
CH - Svizzera 24
EG - Egitto 24
CI - Costa d'Avorio 22
AE - Emirati Arabi Uniti 20
PK - Pakistan 20
UZ - Uzbekistan 19
EU - Europa 17
KE - Kenya 17
PY - Paraguay 17
AU - Australia 16
PE - Perù 16
SA - Arabia Saudita 16
JM - Giamaica 15
CL - Cile 12
ET - Etiopia 12
IL - Israele 12
KZ - Kazakistan 12
AZ - Azerbaigian 11
HU - Ungheria 11
TN - Tunisia 11
CZ - Repubblica Ceca 10
KG - Kirghizistan 10
GR - Grecia 9
LB - Libano 9
LV - Lettonia 9
DO - Repubblica Dominicana 8
HN - Honduras 8
BG - Bulgaria 7
BY - Bielorussia 7
DZ - Algeria 7
MD - Moldavia 7
NO - Norvegia 7
PH - Filippine 7
RO - Romania 7
BO - Bolivia 6
DK - Danimarca 6
LU - Lussemburgo 6
NP - Nepal 6
OM - Oman 6
PA - Panama 6
AL - Albania 5
AM - Armenia 5
HR - Croazia 5
MY - Malesia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
QA - Qatar 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CR - Costa Rica 4
RS - Serbia 4
TW - Taiwan 4
UY - Uruguay 4
BH - Bahrain 3
CG - Congo 3
GA - Gabon 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
NG - Nigeria 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TT - Trinidad e Tobago 3
Totale 26.181
Città #
Chandler 1.702
Singapore 1.690
Ashburn 810
Beijing 382
New York 380
Dublin 343
San Mateo 336
Jacksonville 286
Nürnberg 244
Los Angeles 227
Jakarta 226
Nanjing 210
Hefei 198
Munich 196
Wilmington 183
Ann Arbor 162
Boston 161
Rome 160
Marseille 156
Warsaw 141
Milan 136
Cattolica 126
Moscow 119
The Dalles 117
Dallas 114
Frankfurt am Main 113
Ho Chi Minh City 110
Houston 103
Dearborn 96
Nanchang 96
São Paulo 90
Woodbridge 90
Lawrence 89
Princeton 85
Hong Kong 82
Hanoi 81
Bremen 79
Lancaster 79
Izmir 78
Seattle 77
Buffalo 73
Redwood City 70
Helsinki 69
Fairfield 62
Santa Clara 56
Brussels 55
Tokyo 55
Kent 54
Nuremberg 54
Chicago 53
Leawood 51
Seoul 49
Turku 49
Vienna 45
Düsseldorf 42
Rio de Janeiro 41
London 40
Detroit 38
Phoenix 38
Zhengzhou 38
Hebei 37
San Francisco 37
Shanghai 37
Tianjin 37
Brooklyn 36
Mountain View 36
Norwalk 36
Kraków 35
Kunming 31
University Park 31
Atlanta 30
Baghdad 30
Boardman 30
Curitiba 30
Denver 30
Guangzhou 30
Shenyang 30
Montreal 28
Washington 28
Andover 27
Toronto 27
Amman 26
Chennai 26
Lauterbourg 26
Orem 26
Brasília 25
Changsha 25
North Bergen 25
Augusta 24
Hangzhou 24
Jiaxing 24
Paris 23
Poplar 23
Stockholm 23
Amsterdam 22
Johannesburg 22
Pune 22
Abidjan 21
Bexley 21
Dhaka 21
Totale 12.307
Nome #
Impact of operator experience and wiring technique on procedural efficacy of trans-radial percutaneous chronic total occlusion recanalization performed by dedicated radialists 285
Anti-tissue transglutaminase antibodies from celiac patients are responsible for trophoblast damage via apoptosis in vitro 256
Management of the access site after transradial percutaneous procedures: literature overview 254
Comparison of Right and Left Upper Limb Arterial Variants in Patients Undergoing Bilateral Transradial Procedures 251
Clinical and procedural impact of aortic arch anatomic variants in carotid stenting procedures 242
Safety and efficacy of G-CSF in patients with ischemic heart failure: The CORNER (Cell Option for Recovery in the Non-Eligible patients for Revascularization) study. 241
Frequency domain optical coherence tomography to assess non-ostial left main coronary artery 233
Prospective evaluation of myocardial ischemia related to post-procedural side-branch stenosis in bifurcated lesions treated by provisional approach with drug-eluting stents. 227
Renal artery stenting in patients with chronic ischemic heart disease 224
The HEART study: a real-world experience using the CID Chrono Carbostent in primary and rescue PCI 222
Differences in Microparticle Release in Patients With Acute Coronary Syndrome and Stable Angina 218
Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): A randomized pilot clinical trial 218
Baseline C-Reactive Protein Serum Levels and In-Stent Restenosis Pattern After m-TOR Inhibitors Drug-Eluting Stent Implantation 216
Human cardiac progenitor cells with regenerative potential can be isolated and characterized from 3D-electro-anatomic guided endomyocardial biopsies 214
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 209
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 206
Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate 205
Effects of bariatric surgery on cardiac remodeling: clinical and pathophysiologic implications 199
Outcome of non-cardiac surgery after stent implantation in the DES era: results of the Surgery After Stent (SAS) registry 195
Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions 194
A case of fatal stent thrombosis after Carbostent implantation: Is clopidogrel alone antiplatelet therapy a safe alternative to aspirin alone antiplatelet therapy 193
Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents 192
Endothelial progenitor cells in morbid obesity 190
Optical coherence tomography features of angiographic complex and smooth lesions in acute coronary syndromes 186
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery 181
Vascular complications and access crossover in 10,676 transradial percutaneous coronary procedures 180
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 178
Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role 178
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry 176
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 174
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 173
Characterization of microvascular and myocardial damage within perfusion defect area at myocardial contrast echocardiography in the subacute phase of myocardial infarction 171
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). 169
Eosinophil cationic protein and clinical outcome after bare metal stent implantation 165
Angiographically intermediate left main bifurcation disease assessment by frequency domain optical coherence tomography (FD-OCT) 165
A current approach to heart failure in Duchenne muscular dystrophy 164
Case-control registry of excimer laser coronary angioplasty versus distal protection devices in patients with acute coronary syndromes due to saphenous vein graft disease 163
Limitations of noninvasive measurement of fractional flow reserve from coronary computed tomography angiography 160
In vitro cardiomyocyte differentiation of umbilical cord blood cells: crucial role for c-kit(+) cells 159
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention 159
Angiographic assessment of myocardial perfusion in Tako-Tsubo syndrome 157
Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome 157
Fractional Flow Reserve or Optical Coherence Tomography to Guide Management of Angiographically Intermediate Coronary Stenosis: A Single-Center Trial 157
Are endothelial progenitor cells mobilized by myocardial ischemia or myocardial necrosis? A cardiac magnetic resonance study 156
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 156
Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role 156
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 156
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function 152
Eosinophil cationic protein and clinical outcome after bare metal stent implantation 151
Coronary bifurcation lesions: to stent one branch or both? A meta-analysis of patients treated with drug eluting stents. 151
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 151
Corrigendum to 'Morphological and functional consequences of transradial coronary angiography on the radial artery: implications for its use as a bypass conduit' [Eur J Cardiothorac Surg 2015;48:370-4]† 151
Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials 151
Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: A prospective study 148
Effects of late REopening of Coronary total Occlusion on micRovascular perfusion and myocarDial function: the RECORD study 148
Anti-transglutaminase antibodies from celiac patients are responsible for trophoblast damage via apoptosis in vitro 147
Frequency-domain optical coherence tomography findings in patients with bifurcated lesions undergoing provisional stenting 146
Resolute zotarolimus-eluting stent to treat bifurcated lesions according to the provisional technique: a procedural performance comparison with sirolimus- and everolimus-eluting stents 146
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 146
Parvovirus B19 at the culprit coronary stenosis predicts outcome after stenting 141
Influence of the amount of myocardium subtended by a stenosis on fractional flow reserve 141
Correlation between CD4 + CD28 null T lymphocytes, regulatory T cells and plaque rupture: An Optical Coherence Tomography study in Acute Coronary Syndromes 141
EuroSCORE predicts long-term mortality of unselected patients undergoing percutaneous coronary interventions 141
Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries 141
Interplay Between Myocardial Bridging and Coronary Spasm in Patients With Myocardial Ischemia and Non-Obstructive Coronary Arteries: Pathogenic and Prognostic Implications 140
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 139
Impact of drug-eluting balloon (pre- or post-) dilation on neointima formation in de novo lesions treated by bare-metal stent: the IN-PACT CORO trial 139
From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells 136
Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents. 135
Ethanol abolishes ischemic preconditioning in humans 134
Human cardiac progenitor cells with regenerative potential can be isolated and characterized from 3D-electro-anatomic guided endomyocardial biopsies 134
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 133
Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention 132
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 131
Association between inflammatory biomarkers and in-stent restenosis tissue features: an Optical Coherence Tomography Study 131
Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography 129
Radial artery complications occurring after transradial coronary procedures using long hydrophilic-coated introducer sheath: a frequency domain-optical coherence tomography study 129
Response to letter regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery" 129
Differential levels of circulating progenitor cells in acute coronary syndrome patients with a first event versus patients with recurring events 128
Anti-tissue transglutaminase antibodies from celiac patients are responsible for trophoblast damage via apoptosis in vitro 128
Frequency-domain optical coherence tomography assessment of kissing-balloon effects in bifurcated coronary artery lesions undergoing provisional stenting 128
The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial 128
Myocardial bridge evaluation towards personalized medicine: study design and preliminary results of the RIALTO registry 126
Effect of Exercise on Circulating Endothelial Progenitor Cells in Microvascular Angina 126
No-reflow reversibility: a study based on serial assessment of multiple biomarkers 126
Differential levels of circulating progenitor cells in acute coronary syndrome patients with a first event versus patients with recurring events 124
Effects of late REopening of Coronary total Occlusion on micRovascular perfusion and myocarDial function: the RECORD study 124
Predictors of fractional flow reserve/instantaneous wave-free ratio discordance: impact of tailored diagnostic cut-offs on clinical outcomes of deferred lesions 122
Anti-tissue transglutaminase antibodies from celiac patients are responsible for trophoblast damage via apoptosis in vitro 121
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 121
Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries 121
Infarct-related artery occlusion, tissue markers of ischemia, and increased apoptosis in the peri-infarct viable myocardium. 120
Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction) 120
Impact of accuracy of fractional flow reserve to reduction of microvascular resistance after intracoronary adenosine in patients with angina pectoris or non-ST-segment elevation myocardial infarction 120
Dual role of circulating endothelial progenitor cells in stent struts endothelialisation and neointimal regrowth: a substudy of the IN-PACT CORO trial 120
Effect of exercise on circulating endothelial progenitor cells in microvascular angina 119
Fractional flow reserve or optical coherence tomography guidance to revascularize intermediate coronary stenosis using angioplasty (FORZA) trial: study protocol for a randomized controlled trial 118
Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease 118
Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trials 117
Clinical Impact of Heart Team Decisions for Patients With Complex Valvular Heart Disease: A Large, Single-Center Experience 116
Totale 16.135
Categoria #
all - tutte 108.110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.110


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021747 0 0 0 0 0 98 151 47 175 55 175 46
2021/20221.876 127 112 35 100 98 63 57 333 70 143 336 402
2022/20234.182 525 615 363 689 190 521 231 352 514 38 87 57
2023/20242.107 82 520 74 86 82 401 125 109 51 69 269 239
2024/20254.567 94 143 309 212 384 129 146 243 724 464 1.011 708
2025/20266.349 1.701 333 643 1.271 2.006 395 0 0 0 0 0 0
Totale 26.583